Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

biotech word cloud

Analysts Make Major Changes to Top Biotech Ratings

At different times of the year, certain sectors come alive or slow down. Typically each year, the first quarter is the slowest for the biotechs, so many analysts tend to ...
Read Full Story »
ThinkstockPhotos-475472230

Top Analyst Upgrades and Downgrades: Amazon, Ford, Gilead, Level 3, Sarepta, Western Digital, Whiting Petroleum and More

Stocks had a rough Thursday and futures were indicated lower on Friday. Despite the drop, we have yet to see any serious selling pressure in a while and investors still ...
Read Full Story »
biotech word cloud

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the April 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Test tubes

4 Biotechs That Will Escape Weak Seasonal Trends for the Sector

All sectors of the market tend to have times of the year that are better than others, and biotechnology is no different. Typically each year, the first quarter is the ...
Read Full Story »
biotech word cloud

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the March 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
biotech word cloud

Short Sellers Back Off of Major Biotechs

The short interest data are out for the February 29 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
biotech word cloud

Why Citi Sees Huge Upside in 4 Top Biotechs Now

If there was one sector inside of a broader health care theme that performed well through much of 2015, it was biotech. That was then, and this is now. A ...
Read Full Story »
graph

Short Interest Rises Across the Board in Major Biotechs

The short interest data are out for the February 12 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
biotech word cloud

Major Biotech Short Interest Continues to Be Mixed

The short interest data are out for the January 29 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: GoPro, Illumina, Mattel, Match, Peabody, Petrobras, Wayfair, Yahoo and More

Stocks were indicated lower on Thursday after having been in positive territory in the wee-hours of the futures trading. Another rally has been used as an opportunity to sell, even ...
Read Full Story »
biotech word cloud

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the January 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Test tubes

Short Interest Remains Mixed for Major Biotechs

The short interest data are out for the December 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
biotech word cloud

Short Interest Remains Mixed in Major Biotechs

The short interest data are out for the December 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
ThinkstockPhotos-474136438

Insider Selling Highlights: Cisco, Shake Shack and More (Updated)

You talk about a roller-coaster ride, this past week in the stock market was the epitome. Following a huge rally after the Federal Reserve raised rates for the first time ...
Read Full Story »
biotech word cloud

Mixed Views on Major Biotech Short Interest

The short interest data are out for the November 30 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »